Gopal C. Kundu

Tumor-Stroma Interaction, Understanding Tumor Heterogeneity in Tumor Microenvironment, Regulation of Gene Expression, Targeted Drug Delivery & Development, Angiogenesis, Cancer Stem Cells, Chemical Biology and Nanotechnology

Ph.D., (Chemistry), "Purification and characterization of serine proteinase inhibitor from artocarpus integrifolia seeds". Bose Institute, Calcutta University, India (1989))

Chairman, Research, Development and Innovation, KIIT Deemed to be University

Cancer Biology; Science and Society

• Shanti Swarup Bhatnagar Prize from CSIR, Govt. of India, 2004
• Natl Biosci Award from DBT, Govt. of India, 2003-04
• Intl Young Invest Award, 5th Mayo Clinic Angiogenesis Sym, USA, 2012
• Intl Award for an outstanding achievement in Oncology, Greece, 2007
• Platinum Jubilee Award Lecture, 99th ISCA, 2012
• 7th Natl Grassroots Innov Award, New Delhi, 2013
• Sir J C Bose National Fellowship from ANRF, 2024

• J.C Bose Fellowships. ANRF (earlier SERB), Govt. of India, Rs. 72.11 Lakhs
• An integrated assessment to improve the efficacy of gene expression based PAM50 classifier with additional miRNA and epigenetic signature to improve prognostication in Breast Cancer using PDX based platform. ICMR, Govt. of India, Rs. 1.19 Crores
• DZNepA as a therapeutic drug candiadate for breast cancer treatment. DBT, Govt. of India, Rs.98.75 lakhs
• Targeting Nucleoin for Refining Anti-Neoplastic Chem--- Immunomod in B-Cell Lymphoma. ANRF, Govt. of India. Rs. 56.43 lakhs
• Deciphering Osteopontin Driven -- in TNBC using Dead Cas9- based tools. DBT, Govt. of India, Rs. 37.78 lakhs
• Multi-Omics Analysis to Decipher Mechanisms of -- in Breast Cancer. DBT, Govt. of India. Rs. 1.70 Crores
• Determination –resistant biofilm infections. ICMR, Govt. of India . Rs. 29.13 lakhs
• Multipronged approach for pre-clinical ---breast cancer therapy.DBT, Govt. of India. Rs. 96.12 lakhs

• Fellow of Indian National Science Academy (2023)
• Fellow of Royal Society of Chemistry (2023)
• Fellow of the National Academy of Sciences, India (2003)
• Fellow of the Indian Academy of Sciences (2006)
• Fellow of Maharashtra Academy of Science
• Editorial Board Member of Current Molecular Medicine, USA (2006)
• Editorial Board Member of Molecular Medicine Reports, Greece (2007)
• Senior Editorial Board Member of American Journal of Cancer Research (2011)
• Associate Editor, J. of Cancer Metastasis and Treatment (2015-)
• Editorial Board Member, World Academy of Sciences, Greece
• Editorial Board Member, Current Chemical Biology, USA
• Associate Editor, Molecular Cancer (IF: 33.3) (2015-till date)
• Member of American Society for Biochemistry and Molecular Biology, USA (2006)
• Member of Molecular Immunology Forum (MIF)
• Member of New York Academy of Sciences, USA (2000-2001)
• Member of Guha Research Conference (GRC) (2003)

• A. B. Mukherjee, USA; Gopal C. Kundu, India--: 2002, Methods--restenosis. US Patent No. US 6,458,590 B1
• Gopal C. Kundu, et al. Stable Nanoparticles-- Pharmaceutical Composition. Indian Patent No: 459538
• Srivastava Rohit, ----Kundu Gopal C. Red --process for preparing the same. Indian Patent No: 486170
• KUNDU, Gopal C.; WEBER, G F: A Novel--of Cancer. Indian Patent Application Provisional No. 201821040459